Hepion Pharmaceuticals, Inc.
HEPA
$0.32
$0.02257.56%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 68.20% | -23.97% | -37.54% | 74.20% | -5.06% |
| Total Depreciation and Amortization | -- | -- | -100.00% | 150.41% | -33.51% |
| Total Amortization of Deferred Charges | 67.34% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1,059.27% | 99.15% | -435.31% | -66.35% | 2,129.68% |
| Change in Net Operating Assets | -97.68% | 176.38% | -17.19% | -9.91% | -114.34% |
| Cash from Operations | 54.21% | 76.96% | -202.16% | 59.82% | 19.89% |
| Capital Expenditure | -- | -- | -- | -- | -111.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -- | -- | -- | -111.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -100.00% | -58.85% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -- | -100.00% | -58.85% | -- |
| Foreign Exchange rate Adjustments | -- | 100.00% | -171.28% | 863.33% | 325.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -76.52% | 94.38% | -554.04% | 62.64% | 59.97% |